Ali A. Habib

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial

James F. Howard, Vera Bril, Tuan Vu et al. · The Lancet Neurology · 2021 · 668 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +4

Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study

James F. Howard, Saskia Bresch, Angela Genge et al. · The Lancet Neurology · 2023 · 250 citations

Medicine, Pharmacotherapy, Pain Management +2

Clinical Effects of the Self-administered Subcutaneous Complement Inhibitor Zilucoplan in Patients With Moderate to Severe Generalized Myasthenia Gravis

James F. Howard, Richard J. Nowak, Gil I. Wolfe et al. · JAMA Neurology · 2020 · 193 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Intron mutations and early transcription termination in Duchenne and Becker muscular dystrophy

Megan A. Waldrop, Steven A. Moore, Katherine D. Mathews et al. · Human Mutation · 2022 · 50 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Varicella zoster virus meningitis with hypoglycorrhachia in the absence of rash in an immunocompetent woman

Ali A. Habib, Don Gilden, D. Scott Schmid et al. · Journal of NeuroVirology · 2009 · 44 citations · Full text

Veterinary Medicine, Infectious Diseases, Microbiology +12